The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II

P. J. Talmud; J. A. Cooper; H. Hattori; I. P. Miller; G. J. Miller; S. E. Humphries

首页> 外文期刊>Diabetologia >The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II

【24h】

The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II

机译：载脂蛋白A-V基因型和血浆载脂蛋白A-V和甘油三酸酯水平：2型糖尿病的潜在风险。诺斯威克公园心脏研究II的结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

We sought to establish the relationship between plasma apolipoprotein A-V (APOA5, previously known as apoA-V) and triglyceride levels and to determine the impact of the APOA5 genotype on APOA5 levels and development of type 2 diabetes in a 15-year follow-up study of healthy UK men.

机译：在15年的随访研究中，我们试图建立血浆载脂蛋白AV（APOA5，以前称为apoA-V）与甘油三酸酯水平之间的关系，并确定APOA5基因型对APOA5水平和2型糖尿病发展的影响。健康的英国男人。

著录项

来源
《Diabetologia》 |2006年第10期|2337-2340|共4页
作者
P. J. Talmud; J. A. Cooper; H. Hattori; I. P. Miller; G. J. Miller; S. E. Humphries;
展开▼
作者单位

Division of Cardiovascular Genetics Department of Medicine Royal Free and University College Medical School;

Division of Cardiovascular Genetics Department of Medicine Royal Free and University College Medical School;

Department of Advanced Medical Technology and Development Biomedical Laboratories Inc;

Cardiovascular Genetics Division Department of Internal Medicine University of Utah School of Medicine;

Medical Research Council Cardiovascular Group Centre for Environmental and Preventive Medicine Wolfson Institute of Preventive Medicine;

Division of Cardiovascular Genetics Department of Medicine Royal Free and University College Medical School;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
APOA5; ApoAV levels; Gene; Type 2 diabetes risk;

机译：APOA5;ApoAV水平;基因;2型糖尿病风险;

相似文献

外文文献
中文文献
专利

1. Administration of a PPAR alpha agonist increases serum apolipoprotein A-V levels and the apolipoprotein A-V/apolipoprotein C-III ratio [J] . Schultze AE, Alborn WE, Newton RK, Journal of Lipid Research . 2005,第8期

机译：施用PPARα激动剂可提高血清载脂蛋白A-V水平和载脂蛋白A-V /载脂蛋白C-III的比例
2. Administration of a PPARalpha agonist increases serum apolipoprotein A-V levels and the apolipoprotein A-V/apolipoprotein C-III ratio. [J] . Schultze AE, Alborn WE, Newton RK, Journal of Lipid Research . 2005,第8期

机译：PPARalpha激动剂的使用会增加血清载脂蛋白A-V水平和载脂蛋白A-V /载脂蛋白C-III的比例。
3. Association of SNP3 polymorphism in the apolipoprotein A-V gene with plasma triglyceride level in Tunisian type 2 diabetes [J] . Raja Chaaba, Nebil Attia, Sonia Hammami, Lipids in Health Disease . 2005,第1期

机译：突尼斯2型糖尿病患者载脂蛋白A-V基因SNP3多态性与血浆甘油三酯水平的关系
4. Structure-function analysis of apolipoprotein A-V: Insight into plasma triglyceride homeostasis. [D] . Mauldin, Kasuen. 2010

机译：载脂蛋白A-V的结构功能分析：深入了解血浆甘油三酸酯的体内稳态。
5. Association of SNP3 polymorphism in the apolipoprotein A-V gene with plasma triglyceride level in Tunisian type 2 diabetes [O] . Raja Chaaba, Nebil Attia, Sonia Hammami, 2005

机译：突尼斯2型糖尿病患者载脂蛋白A-V基因SNP3多态性与血浆甘油三酸酯水平的关系
6. The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II [O] . P. J. Talmud, J. A. Cooper, H. Hattori, 2006

机译：载脂蛋白A-V基因型和血浆载脂蛋白A-V和甘油三酯水平：2型糖尿病的前瞻性风险。北威克公园心脏研究的结果

The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II

摘要

著录项

相似文献

相关主题

期刊订阅